SCHEMBL8523338

SCHEMBL8523338

O=C(O)c1c(CN2CCOCC2)[nH]c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
MAPT P10636 2/20 0.54
ALOX15 P16050 2/20 0.54
TSHR P16473 2/20 0.54
CHRM3 P20309 3/20 0.51
HTT P42858 2/20 0.50
HSD17B10 Q99714 1/20 0.50
DRD2 P14416 2/20 0.49
DRD4 P21917 2/20 0.49
DRD3 P35462 2/20 0.49
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
GAA P10253 1/20 0.47
KDM4E B2RXH2 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
PARP1 P09874 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31025920 0.79 HSD17B10 (0.70) ALDH1A1MAPTALOX15TSHRCHRM3
SCHEMBL18886833 0.79 HSD17B10 (0.70) ALDH1A1MAPTALOX15TSHRCHRM3
SCHEMBL9684170 0.75 MEN1 (0.51) ALDH1A1MAPTALOX15TSHRDRD2
SCHEMBL6014774 0.75 KDM4E (0.61) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL29612041 0.73 CYP2C9 (0.58) ALDH1A1MAPTALOX15TSHRCHRM3
SCHEMBL6964299 0.72 KDM4E (0.57) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL30602834 0.72 KDM4E (0.57) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL16880202 0.72 HDAC6 (0.53) ALDH1A1MAPTKMT2AGAAPARP1
SCHEMBL6768412 0.72 HSD17B10 (0.51) ALDH1A1MAPTALOX15HTTHSD17B10
SCHEMBL16880356 0.71 MAPK1 (0.52) ALDH1A1MAPTALOX15TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999043323-A1 COMPOUNDS AND METHODS FOR CHEMOSENSITIZING MULTIDRUG RESISTANT CELLS FOX CHASE CANCER CENTER (US) 1999-09-02 WO disclosed